Managing IP’s China IP Special Focus 2022 launched

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Managing IP’s China IP Special Focus 2022 launched

editorial-adobestock-16451032.jpg

Managing IP has partnered with leading IP experts to share knowledge and solutions on China’s IP landscape in 2022

The fourth amendment to China’s Patent Law came into force on June 1 2021 reflecting the need to strengthen IP protection. There are many highlights of this revision that the IP experts will explore in depth as well as a wide range of other relevant developments in China’s IP terrain.

AFD China Intellectual Property Law Office discuss the development of the law regarding OEMs and trademark infringement in China while Beijing East IP consider why adopting and promoting a Chinese equivalent of a foreign language mark is critical for foreign businesses to shine in China’s market.

Administrative actions are an important tool for IP protection in China. CCPIT Patent and Trademark Law Office discuss how they can be used in practice and what advantages they offer. Chang Tsi & Partners explain why Chinese enterprises dealing with SEP litigation should respond actively to ensure the issue is litigated before the Chinese courts.

DEQI Intellectual Property’s article focusses on why the patent prosecution highways programme is the most and active international cooperation programme in patent examination around the world. While Kangxin explain why applicants and patentees should understand the functionality of the compensation system for the patent protection term

Liu Shen & Associates provide an analysis of IP cases decided by China’s Supreme Court and consider the characteristics of each. Panawell & Partners explain why the patent evaluation report plays an important role in patent infringement litigation.

Vivien Chan & Co explain how brand owners can benefit from the changes introduced by the CNIPA including reducing bad faith filings and Wanhuida Intellectual Property provide an insight into obtaining evidence on the infringing product/process and the calculation of damages in China.

We hope you enjoy hearing from the IP experts on a wide range of topics in the China IP Special Focus 2022.

Click here to read all the chapters from Managing IP's China IP Special Focus 2022 

more from across site and SHARED ros bottom lb

More from across our site

Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
The initial contempt of court claim targeted Stobbs and the firm’s client for allegedly interfering with the administration of justice
Acquisition of platform developed by Boehmert & Boehmert lawyer set to create a combined platform for patent drafting and prosecution in Europe
Partner Rob Jacob unveils plans to offer a beginning-to-end trademark service, how to make prosecution profitable, and why IP ‘buy-in’ from the CEO stands the firm in good stead
Sponsored by CAS
CAS provides practical pointers on how intellectual property and R&D teams can work in tandem to unlock tangible benefits and avoid wasted spend
Sponsored by CAS
CAS explores how AI is transforming intellectual property, from inventorship and copyright disputes to new demands on patent attorneys
Sponsored by That.Legal
Gillian Tan of That.Legal discusses a recent decision by the Intellectual Property Office of Singapore and what it reveals about the evidential burden in bad-faith trademark claims
Attorneys at Di Blasi, Parente & Associados share how the protection of trade secrets strengthens innovation by bringing together legal practice, regulatory developments, and established international references
Jin Ooi, who joins as a partner today, said he is excited to offer a ‘rounded’ IP service as the firm deepens its litigation expertise in the UK and Europe
As generics celebrate, practitioners believe innovator companies should brace for an ‘uphill battle’ when trying to prove induced infringement
Gift this article